Page 222 - Basic Monitoring in Canine and Feline Emergency Patients
P. 222

procainamide  58                             sick sinus syndrome (SSS)  64
            protease inhibitor  183                      sinoatrial (SA) node  45–46, 47, 52, 56, 59–68
  VetBooks.ir  proteinuria  43                           sinus node dysfunction (SND)  64
                                                         sinus, arrhythmia  52, 56, 56
            proteins  5, 15, 100, 183
                                                         sinus rhythms  52–56, 52, 56, 62
            prothrombin time (PT)  149–152, 187–188,
                  192–196, 193                           sodium (Na)  29, 66, 89, 156–158, 162–164, 168–169
            prothrombinase complexes  180–181, 184       sphygmomanometer  33
            pulmonary fibrosis  93                       splenic contraction  15
            pulmonary–pleural line (PPL)  138, 139, 142  splenoral (SR) view  137
            pulse oximeter (SpO2)  71–74, 80–83, 127     step signs  138–140, 139
            pulse oximetry  71–83, 127                   sulfur dioxide (SO )  98
                                                                     2
            Purkinje fibers  45                          supraventricular ectopy  59
            pyometra  200                                supraventricular premature complex (SVPC)  60–61, 65
            pyrexia  43                                  sympathetic nervous system (SNS)  46, 50, 56
            pyruvate  3, 4                               systemic vascular resistance (SVR)  28–29, 29, 37–38


            QRS complex  45, 48–51, 52, 56–62, 59, 63–65, 66–69  T waves  50–51, 52, 59–61, 65, 68
                                                         tachyarrhythmia  40, 50, 67–68, 67
                                                            differentiation algorithm  62
            R-R intervals  52, 61–64, 67–68              tachycardia  43, 62–64, 190
            rate/rhythm/pressure (heart)  12, 20–21, 29     sinus  56, 56, 64
                calculation and analysis  50–51, 51, 51     supraventricular (SVT)  59–64, 60
            re-entrant loops  59                            ventricular (VT)  56–58, 59, 62
            rebreathing  120–122, 123                    tachypnea  22, 79, 99, 106, 146, 195
                causes  120–122                          target organ damage (TOD)  36, 39, 42–43
            red blood cells (RBCs)  5, 18–19             temperature  10–11
            renin-angiotensin-aldosterone system (RAAS)  29–30,   thoracentesis  148
                  29–30, 38–39                           thoracic focal assessment for trauma/triage/tracking
                                                                    3
            repolarization  45                                 (TFAST )  129–142, 134–135, 139, 145–152
                ventricular  45, 50                      3betahydroxybutyrate (3-HB)  2, 7, 16
            respiratory acidosis  86, 88, 99–100, 103, 106  thrombin  179–183, 187
            respiratory alkalosis  86, 87–88, 90–100, 104, 107,   thrombocytopathia  184, 189–191
                  165–166                                thrombocytopenia  106, 184, 188–193, 188–189, 196–197
            retina  36                                      immune-mediated (ITP)  188, 191
            return of spontaneous circulation (ROSC)  125   pseudo- 192
            rhabdomyolysis  161                          thrombocytosis  169–170
            rickettsial disease  197                     thromboelastography (TEG)  188
                polymerase chain reaction  43            thromboembolism  102, 128
            Ringers solution  169, 199                   thrombomodulin  183
            rodenticide intoxication  190, 195           thrombosis  195
            rotational thromboelastometry (ROTEM)  188   thromboxane  190
                                                         tick-borne diseases  188, 192
                                                         tissue, perfusion  14, 31, 200
            salicylates  170                             tissue factor pathway inhibitor (TFPI)  183, 184
            Sanz electrode  98                           tissue factor (TF)  135, 139, 142, 148, 179–180, 180,
            saturation of oxygen (SaO )  71–76, 81–82, 92, 98  187–188
                              2
            Seldinger technique  145                     tissue plasminogen activator (tPA)  182
            sepsis  16, 179                              toxins  9, 52, 88, 105, 192
            serotonin  177                               Trauma Score  13
            serum chemistry (CHEM)  149                  tricarboxylic (TCA) cycle  1–3
            serum chloride (Cl)  156
            shock  9–11, 13, 39–43, 50, 69
                hypovolemic  37                          uremia  105
                septic  37                               urinalysis  20, 43
            shred signs  135, 138–142, 139               urinary collection system  201
            shunt fraction  112                          urine protein-to-creatinine (UPC) ratio  43


             214                                                                            Index
   217   218   219   220   221   222   223   224   225